Are they safe? Drugs and devices receiving accelerated approval by the FDA episode artwork

EPISODE · Aug 15, 2017 · 27 MIN

Are they safe? Drugs and devices receiving accelerated approval by the FDA

from JAMA Clinical Reviews

Some drugs and devices receive accelerated approval from the FDA in order to provide potentially important treatments for patients when effective therapies may not be available. These drugs or devices are supposed to have postmarketing studies to definitively show their efficacy or safety, but sometimes this doesn't happen. Rita F. Redberg, MD, MSc, Aaron S. Kesselheim, MD, JD, MPH, and Robert M. Califf, MD, discuss their articles characterizing studies used for the approval of high-risk medical devices and accelerated approval of drugs by the FDA. Discussed in this podcast: FDA Online

Episode metadata supplied by the publisher feed · Published Aug 15, 2017

Embed this episode

NOW PLAYING

Are they safe? Drugs and devices receiving accelerated approval by the FDA

0:00 27:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Clinical Reviews?

This episode is 27 minutes long.

When was this JAMA Clinical Reviews episode published?

This episode was published on August 15, 2017.

Can I download this JAMA Clinical Reviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!